These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33162839)

  • 21. Potential impact of lateral lymph node dissection (LLND) for low rectal cancer on prognoses and local control: A comparison of 2 high-volume centers in Japan that employ different policies concerning LLND.
    Kanemitsu Y; Komori K; Shida D; Ochiai H; Tsukamoto S; Kinoshita T; Moriya Y
    Surgery; 2017 Aug; 162(2):303-314. PubMed ID: 28366499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncological outcomes of lateral lymph node dissection (LLND) for locally advanced rectal cancer: is LLND alone sufficient?
    Ishibe A; Watanabe J; Suwa Y; Suzuki S; Nakagawa K; Suwa H; Ozawa M; Ota M; Fujii S; Ike H; Ichikawa Y; Endo I
    Int J Colorectal Dis; 2021 Feb; 36(2):293-301. PubMed ID: 32965528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distant Metastasis is the Dominant Cause of Treatment Failure after Lateral Lymph Node Dissection in Patients with Lateral Lymph Node Metastasis: Results of the Large Multicenter Lateral Node Study in China.
    Li K; Wang F; Jiang Y; Hong G; Li Z; Liang J; Wu W; Xing W; Liu Q
    J Cancer; 2023; 14(17):3227-3237. PubMed ID: 37928432
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparison on efficacy between fascia-oriented versus vascular-oriented lateral lymph node dissection in patients with rectal cancer].
    Wang ZJ; Liu Z; Liang JW; Zhang MG; Mei SW; Shen HY; Chen JN; Li J; Zhao FQ; Wei FZ; Xiao TX; Liu Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jul; 24(7):611-618. PubMed ID: 34289546
    [No Abstract]   [Full Text] [Related]  

  • 25. Total mesorectal excision with and without lateral lymph node dissection: a systematic review of the literature.
    Longchamp G; Meyer J; Christou N; Popeskou S; Roos E; Toso C; Buchs NC; Ris F
    Int J Colorectal Dis; 2020 Jul; 35(7):1183-1192. PubMed ID: 32458399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of synchronous lateral pelvic nodal metastasis in rectal cancer in the era of neoadjuvant chemoradiation: A systemic review.
    Wong JSM; Tan GHC; Chia CS; Ong CJ; Teo MCC
    World J Gastrointest Surg; 2020 May; 12(5):247-258. PubMed ID: 32551030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncological Impact of Lateral Lymph Node Dissection After Preoperative Chemoradiotherapy in Patients with Rectal Cancer.
    Kim MJ; Chang GJ; Lim HK; Song MK; Park SC; Sohn DK; Chang HJ; Kim DY; Park JW; Jeong SY; Oh JH
    Ann Surg Oncol; 2020 Sep; 27(9):3525-3533. PubMed ID: 32385767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive lateral pelvic lymph nodes in low rectal cancer: should we change our practice now?
    Gartrell R; Hong MK; Baker A; Master M; Gibbs P; Arslan J; Croxford M; Yeung JM; Faragher IG
    ANZ J Surg; 2021 May; 91(5):947-953. PubMed ID: 33792140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indications and oncological outcomes of selective dissection for clinically suspected lateral lymph node metastasis in patients with rectal cancer based on pretreatment imaging.
    Yang X; Gu C; Hu T; Wei M; Meng W; Wang Z; Deng X; Zhou Z
    Tech Coloproctol; 2021 Apr; 25(4):425-437. PubMed ID: 33585985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Japanese Evidences on Nerve-Preserving Lateral Pelvic Lymh Node Dissection for Rectal Cancer: Major Historical Milestones and Clinical Impact: The Past, Present and Future.
    Kanemitsu Y; Shida D; Tsukamoto S; Moritani K; Sakamoto R
    Clin Colon Rectal Surg; 2020 Nov; 33(6):349-354. PubMed ID: 33223969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rise and fall of total mesorectal excision with lateral pelvic lymphadenectomy for rectal cancer: an updated systematic review and meta-analysis of 11,366 patients.
    Anania G; Davies RJ; Arezzo A; Bagolini F; D'Andrea V; Graziosi L; Di Saverio S; Popivanov G; Cheruiyot I; Cirocchi R; Donini A
    Int J Colorectal Dis; 2021 Nov; 36(11):2321-2333. PubMed ID: 34125269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Outcomes of Total Mesorectal Excision and Lateral Lymph Node Dissection following Neoadjuvant Chemotherapy for Lower Rectal Cancer with Lateral Lymph Node Metastasis].
    Morohashi H; Uchida C; Ogasawara H; Hara Y; Akaishi T; Yachi T; Wakasa Y; Mitsuhashi Y; Tsuruta S; Sato K; Yoshida T; Umetsu S; Hasebe T; Suto A; Hakamada K
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):1803-1805. PubMed ID: 30692359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controversies in the Management of Lateral Pelvic Lymph Nodes in Patients With Advanced Rectal Cancer: East or West?
    Otero de Pablos J; Mayol J
    Front Surg; 2019; 6():79. PubMed ID: 32010707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pay attention to the selective lateral pelvic lymph node dissection in mid-low rectal cancer].
    Meng W; Wang Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):258-262. PubMed ID: 28338156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial.
    Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Murata K; Akagi Y; Takiguchi N; Saida Y; Nakamura K; Fukuda H; Akasu T; Moriya Y;
    Ann Surg; 2017 Aug; 266(2):201-207. PubMed ID: 28288057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative lateral lymph node features and impact on local recurrence after neoadjuvant chemoradiotherapy and total mesorectal excision for locally advanced rectal cancer: results from a multicentre international cohort study.
    Achilli P; Ferrari D; Calini G; Bertoglio CL; Magistro C; Origi M; Carnevali P; Alampi BD; Giusti I; Ferrari G; Calafiore E; Spinelli A; Grass F; Deslarzes P; Hahnloser D; Abdalla S; Larson DW
    Colorectal Dis; 2024 Mar; 26(3):466-475. PubMed ID: 38243617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of the viability assessment of lateral lymph node metastasis in rectal cancer after neoadjuvant chemoradiotherapy.
    Ozaki K; Kawai K; Nozawa H; Sasaki K; Murono K; Emoto S; Abe H; Ushiku T; Ishihara S
    Int J Colorectal Dis; 2022 Feb; 37(2):467-473. PubMed ID: 35064299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212).
    Tsukamoto S; Fujita S; Ota M; Mizusawa J; Shida D; Kanemitsu Y; Ito M; Shiomi A; Komori K; Ohue M; Akazai Y; Shiozawa M; Yamaguchi T; Bando H; Tsuchida A; Okamura S; Akagi Y; Takiguchi N; Saida Y; Akasu T; Moriya Y;
    Br J Surg; 2020 Apr; 107(5):586-594. PubMed ID: 32162301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncologic impact of lateral lymph node metastasis at the distal lateral compartment in locally advanced low rectal cancer after neoadjuvant (chemo)radiotherapy.
    Akiyoshi T; Yamaguchi T; Hiratsuka M; Mukai T; Hiyoshi Y; Nagasaki T; Ueno M; Fukunaga Y; Konishi T
    Eur J Surg Oncol; 2021 Dec; 47(12):3157-3165. PubMed ID: 34284904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors and histological effects of preoperative chemoradiotherapy for rectal cancer and control of lateral lymph node metastasis.
    Miyakita H; Chan LF; Okada K; Kayano H; Mori M; Sadahiro S; Yamamoto S
    BMC Gastroenterol; 2022 Jul; 22(1):334. PubMed ID: 35804299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.